Squamous cell carcinoma of the lung radiation therapy

Revision as of 16:28, 27 April 2018 by Dildar Hussain (talk | contribs) (→‎Radiation Therapy Regimens)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Squamous Cell Carcinoma of the Lung Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Squamous Cell Carcinoma of the Lung from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Squamous cell carcinoma of the lung radiation therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Squamous cell carcinoma of the lung radiation therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Squamous cell carcinoma of the lung radiation therapy

CDC on Squamous cell carcinoma of the lung radiation therapy

Squamous cell carcinoma of the lung radiation therapy in the news

Blogs on Squamous cell carcinoma of the lung radiation therapy

Directions to Hospitals Treating Squamous cell carcinoma of the lung

Risk calculators and risk factors for Squamous cell carcinoma of the lung radiation therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Shanshan Cen, M.D. [2] Maria Fernanda Villarreal, M.D. [3]

Overview

Radiation therapy is recommended as palliative care among patients who develop advanced stage of squamous cell carcinoma of the lung or symptomatic patients with local involvement (pain, vocal cord paralysis, and hemoptysis). Curative radiation therapy may be indicated in patients who are not suitable for surgery with early stage squamous cell carcinoma of the lung. The main goal of radiation therapy for squamous cell carcinoma of the lung is maximum tumor control with minimal tissue toxicity. There are 2 main types of radiation therapy for squamous cell carcinoma of the lung: external beam radiation therapy and brachytherapy (internal radiation therapy).

Radiation Therapy

  • Radiation therapy for squamous cell carcinoma of the lung, includes:[1]
  • Indications for radiation therapy in squamous cell carcinoma of the lung, include:
  • Sufficient pulmonary reserve
  • Stage I
  • Stage II without fitness for surgery
  • Stage IIIA or IIIB squamous cell carcinoma of the lung and are not fit for chemoradiation
  • Common types of external beam radiation therapy for the treatment of squamous cell carcinoma of the lung, include:

Radiation Therapy Regimens

Shown below is a list of the different regimens radiation therapy for patients with non-small cell lung cancer. The list of regimens has been adapted from the 2014 NCCN Non-small cell lung cancer guidelines.[2]

Usual Dosages for Definitive Radiation Therapy

Administer fractions of 2 Gy over a period of 6 to 7.5 weeks to a total dose of 60 to 74 Gy

Neoadjuvant Radiation Therapy Regimen

Administer fractions of 1.8 to 2 Gy over a period of 5 weeks to a total dose of 45 to 50 Gy

Adjuvant Radiation Therapy Regimens

  • Negative surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 5 to 6 weeks to a total dose of 40 to 54 Gy
  • Positive surgical piece margins: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 54 to 60 Gy
  • Extracapsular nodal extension: Administer fractions of 1.8 to 2 Gy over a period of 6 weeks to a total dose of 60 to 70 Gy
  • Residual tumor: Administer fractions of 2 Gy over a period of 6 to 7 weeks to a total dose of 54 to 60 Gy

Stereotactic Ablative Radiotherapy Usual Dosage

  • Peripheral small tumors: 25 to 34 Gy not fractioned.
  • Peripheral tumors and chest wall tumors larger than 1 cm: 45 to 60 Gy administered in 3 fractions
  • Central or peripheral tumors smaller than 5 cm: 48 to 60 Gy administered in 4 fractions
  • Central or peripheral tumors principally chest wall tumors smaller that 1 cm: 50 to 55 Gy administered in 5 fractions
  • Central tumors: 60 to 70 Gy administered in 8 to 10 fractions

References

  1. Pattern of use of radiotherapy for lung cancer: a descriptive study. BioMed Central. http://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-14-697#CR6 Accessed on March 1, 2016
  2. http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf


Template:WikiDoc Sources